| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 伏格列波糖; Voglibose | CFN91808 | 83480-29-9 | C10H21NO7 = 267.3 | 20mg | QQ客服：215959384 |
| 肉豆蔻酸单甘油酯; Monomyristin | CFN91748 | 589-68-4 | C17H34O4 = 302.45 | 20mg | QQ客服：1413575084 |
| 棕榈酸甲酯; Methyl hexadecanoate | CFN91753 | 112-39-0 | C17H34O2 = 270.46 | 20mg | QQ客服：1457312923 |
| alpha-三联噻吩; alpha-Terthiophene | CFN91754 | 1081-34-1 | C12H8S3 = 248.38 | 20mg | QQ客服：215959384 |
| 水麦冬酸; Triglochinic acid | CFN91791 | 31795-12-7 | C7H8O6 = 188.13 | 10mg | QQ客服：2159513211 |
| Tetillapyrone; Tetillapyrone | CFN95404 | 363136-43-0 | C11H14O6 = 242.2 | 5mg | QQ客服：215959384 |
| 10-O-trans-对甲氧基肉桂酰梓醇; 10-O-trans-p-methoxycinnamoyl-catalpol | CFN91677 | 201605-27-8 | C25H30O12 = 522.5 | 5mg | QQ客服：3257982914 |
| 10-O-[(E)-3,4-二甲氧基肉桂酰)梓醇; 10-O-[(E)-3,4-Dimethoxycinnamoyl]-catalpol | CFN91676 | 834155-36-1 | C26H32O13 = 552.5 | 5mg | QQ客服：2056216494 |
| 正十八烷; n-Octadecane | CFN91673 | 593-45-3 | C18H38 = 254.49 | 5mg | QQ客服：2056216494 |
| 硫酸安普霉素; Apramycin sulfate | CFN91671 | 65710-07-8 | C21H41N5O11.H2SO4 = 637.66 | 5mg | QQ客服：3257982914 |
| 赤藓红; Erythrosin B | CFN91670 | 568-63-8 | C20H6I4Na2O5 = 879.86 | 5mg | QQ客服：1457312923 |
| 麦芽糖; Maltose | CFN91657 | 69-79-4 | C12H22O11 = 342.30 | 20mg | QQ客服：215959384 |
| 羟基柠檬酸钙盐; Hydroxycitric acid Calcium salt | CFN91645 | 921226-01-9 | C12H10Ca3O16 = 530.4 | 5mg | QQ客服：2159513211 |
| 麦角硫因; L-(+)-Ergothioneine | CFN91629 | 497-30-3 | C9H15N3O2S = 229.3 | 20mg | QQ客服：1413575084 |
| 铁钉菜酚A; Ishophloroglucin A | CFN91620 | N/A | C96H66O48 = 1986.26 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)